High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]

E. Briet; F R Rosendaal; W. Kreuz; V Rasi; K Peerlinck; J. Vermylen; R. Ljung; A Rocino; J. Addiego; J.I. Lorenzo

High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]

E. Briet, F R Rosendaal, W. Kreuz, V Rasi, K Peerlinck, J. Vermylen, R. Ljung, A Rocino, J. Addiego, J.I. Lorenzo

Pediatrisk hematologi

Leiden University Medical Centre

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	162-164
Tidskrift	Thrombosis and Haemostasis
Volym	72
Nummer	1
Status	Published - 1994 nov. 25

Tillgång till dokument

https://www.ncbi.nlm.nih.gov/pubmed/?term=7974368

Citera det här

Briet, E., Rosendaal, F. R., Kreuz, W., Rasi, V., Peerlinck, K., Vermylen, J., Ljung, R., Rocino, A., Addiego, J., & Lorenzo, J. I. (1994). High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]. Thrombosis and Haemostasis, 72(1), 162-164. https://www.ncbi.nlm.nih.gov/pubmed/?term=7974368

@article{685a2d4f4a4c467b9fe2ded56093a418,

title = "High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]",

keywords = "blood clotting factor 8 inhibitor, recombinant blood clotting factor 8, clinical trial, data analysis, drug safety, follow up, hemophilia A, human, letter, meta analysis, priority journal, risk factor, paediatric",

author = "E. Briet and Rosendaal, {F R} and W. Kreuz and V Rasi and K Peerlinck and J. Vermylen and R. Ljung and A Rocino and J. Addiego and J.I. Lorenzo",

year = "1994",

month = nov,

day = "25",

language = "English",

volume = "72",

pages = "162--164",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Schattauer GmbH",

number = "1",

}

Briet, E, Rosendaal, FR, Kreuz, W, Rasi, V, Peerlinck, K, Vermylen, J, Ljung, R, Rocino, A, Addiego, J & Lorenzo, JI 1994, 'High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]', Thrombosis and Haemostasis, vol. 72, nr. 1, s. 162-164. <https://www.ncbi.nlm.nih.gov/pubmed/?term=7974368>

High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]. / Briet, E.; Rosendaal, F R; Kreuz, W. et al.
I: Thrombosis and Haemostasis, Vol. 72, Nr. 1, 25.11.1994, s. 162-164.

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

TY - JOUR

T1 - High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]

AU - Briet, E.

AU - Rosendaal, F R

AU - Kreuz, W.

AU - Rasi, V

AU - Peerlinck, K

AU - Vermylen, J.

AU - Ljung, R.

AU - Rocino, A

AU - Addiego, J.

AU - Lorenzo, J.I.

PY - 1994/11/25

Y1 - 1994/11/25

KW - blood clotting factor 8 inhibitor

KW - recombinant blood clotting factor 8

KW - clinical trial

KW - data analysis

KW - drug safety

KW - follow up

KW - hemophilia A

KW - human

KW - letter

KW - meta analysis

KW - priority journal

KW - risk factor

KW - paediatric

M3 - Letter

SN - 0340-6245

VL - 72

SP - 162

EP - 164

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 1

ER -